Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial

BACKGROUND: In the Preterm Erythropoietin (Epo) NeUroproTection (PENUT) Trial, potential biomarkers of neurological injury were measured to determine their association with outcomes at two years of age and whether Epo treatment decreased markers of inflammation in extremely preterm (<28 weeks’ ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Thomas R., Parikh, Pratik, Comstock, Bryan A., Law, Janessa B., Bammler, Theo K., Kuban, Karl C., Mayock, Dennis E., Heagerty, Patrick J., Juul, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498235/
https://www.ncbi.nlm.nih.gov/pubmed/34619638
http://dx.doi.org/10.1016/j.ebiom.2021.103605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498235/
https://www.ncbi.nlm.nih.gov/pubmed/34619638
http://dx.doi.org/10.1016/j.ebiom.2021.103605

Ejemplares similares